Merck is scaling back its major operations in the UK, raising alarms about Britain’s capacity to retain its thriving life sciences sector amid rising costs and tangled regulations. Industry experts warn that this decision could put the future of the nation’s biotech industry at serious risk
Astellas Pharma has launched an exciting new program offering dedicated lab space exclusively for Japanese biotech start-ups, designed to ignite their growth and fast-track their path to the global stage. This bold initiative is set to unleash innovation and boost international competitiveness like never before
SNBL and Tasso, Inc. have announced a strategic joint venture in Japan aimed at advancing innovative healthcare solutions. This collaboration is set to enhance patient accessibility to advanced diagnostic tools in the region, strengthening both companies’ market presence.
